Germany’s BRAIN Biotech 9M revenue falls 10.5%
Germany’s BRAIN Biotech reports 9M revenue down 10.5%, citing core unit weakness.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.